Study title bioequivalence and characterization of generic drugs.

Ended Awarded Last action

Contract number
HHSF22301001T
Awardee
Awarding agency
Obligated
$1,477,812

Award facts

Contract value 100% obligated
$1,477,812.34 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
B528 Special Studies/Analysis- Regulatory
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Shawnee Mission, KS 66212, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order 4 · Invoice processing support $0
Other Administrative Action 3 · No cost extension for study title bioequivalence and characterization of generic drugs. Extended until 12/31/2016 $0
Other Administrative Action 2 $0
Supplemental Agreement for work within scope 1 $279,126
Original award $1,198,687

Quick answers

Who was awarded contract HHSF22301001T?

HHSF22301001T was awarded to Altasciences Clinical Kansas Inc. by Food and Drug Administration (Department of Health and Human Services) on September 12, 2014.

How much is contract HHSF22301001T worth?

The government has obligated $1,477,812 on HHSF22301001T.

Is contract HHSF22301001T an order under another contract?

Yes. HHSF22301001T is a delivery order under HHSF223201210030I, an indefinite delivery contract.

Was contract HHSF22301001T competed?

The extent of competition for HHSF22301001T was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award